Radiotherapy also induces the expression and release of chemokines such as CXCL9, CXCL10, and CXCL16 in tumor cells, promoting the migration of effector T lymphocytes to tumor sites, modulating the immune status of the TME, and activating the body’s anti-tumor immune response. The gene discussed is CXCL9; the disease is neoplasm.